Medicare Enrolled
Dr. Alan Deutsch, D.O.
Neurology · Neptune, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Deutsch from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deutsch?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Deutsch
Dr. Alan Deutsch is a neurology specialist in Neptune, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Deutsch performed 1,775 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Deutsch received a total of $16,948 from 88 pharmaceutical and/or device companies across 1222 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Deutsch is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 20% volume in NJ
$16,948 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,775
Medicare services
Top 20% in NJ for neurology
Not available
Unique patients (not deduplicated)
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
545 | $100 | $170 |
| Continuous intraoperative neurophysiology monitoring, remote Remote monitoring of nerve and brain function during surgery, billed in 15-minute increments. |
248 | $26 | $225 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
173 | $128 | $350 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
163 | $69 | $150 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
115 | $268 | $421 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
92 | $135 | $200 |
| Ultrasound of brain blood flow An ultrasound test used to examine blood flow within the brain to check for blood clots. |
70 | $145 | $350 |
| Ultrasound of brain blood flow following medication An ultrasound test used to assess blood flow within the brain after a medication has been administered. |
62 | $199 | $325 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
62 | $85 | $165 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
52 | $102 | $325 |
| Limited needle electromyography A test that measures the electrical activity in muscles of the arm, leg, trunk, or head using a needle electrode. This limited study evaluates muscle function and nerve health. |
47 | $16 | $243 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
46 | $65 | $125 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
36 | $191 | $450 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
24 | $146 | $325 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
15 | $72 | $150 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
14 | $376 | $475 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $146 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$16,948
Total received (2018-2024)
Avg $2,421/year across 7 years
Top 19% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
1,222
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,459
2023
$2,611
2022
$2,369
2021
$2,874
2020
$2,028
2019
$2,336
2018
$2,271
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$397
PFIZER INC.
$346
ABBVIE INC.
$328
Celgene Corporation
$287
Lilly USA, LLC
$176
Teva Pharmaceuticals USA, Inc.
$156
UCB, Inc.
$112
Lundbeck LLC
$97
EMD Serono, Inc.
$85
Grifols USA, LLC
$49
SCILEX PHARMACEUTICALS INC.
$48
Takeda Pharmaceuticals U.S.A., Inc.
$47
Biogen, Inc.
$44
ARGENX US, INC.
$33
ACADIA Pharmaceuticals Inc
$32
Alexion Pharmaceuticals, Inc.
$31
Life Molecular Imaging Ltd
$27
SK Life Science, Inc.
$25
Ipsen Biopharmaceuticals, Inc
$18
CSL Behring
$17
Alnylam Pharmaceuticals Inc.
$16
Eisai Inc.
$15
Vanda Pharmaceuticals Inc.
$15
Neurocrine Biosciences, Inc.
$15
Abbott Laboratories
$15
Amgen Inc.
$13
Cycle Pharmaceuticals Inc
$12
Top 3 companies account for 43.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,107
Teva Pharmaceuticals USA, Inc.
$1,272
UCB, Inc.
$1,133
Biogen, Inc.
$936
Alexion Pharmaceuticals, Inc.
$711
Celgene Corporation
$670
ABBVIE INC.
$625
PFIZER INC.
$590
GENZYME CORPORATION
$561
AbbVie Inc.
$553
EMD Serono, Inc.
$526
Lilly USA, LLC
$493
Grifols USA, LLC
$335
Lundbeck LLC
$315
Biohaven Pharmaceutical Holding Company Ltd.
$297
LivaNova USA, Inc.
$287
Amgen Inc.
$277
SK Life Science, Inc.
$255
Janssen Pharmaceuticals, Inc
$248
ARGENX US, INC.
$215
Kyowa Kirin, Inc.
$197
EISAI INC.
$196
Sunovion Pharmaceuticals Inc.
$189
Amneal Pharmaceuticals LLC
$182
E.R. Squibb & Sons, L.L.C.
$163
Currax Pharmaceuticals LLC
$156
Biohaven Pharmaceuticals, Inc.
$151
Sumitomo Pharma America, Inc.
$147
Acorda Therapeutics, Inc
$140
ACADIA Pharmaceuticals Inc
$126
Adamas Pharmaceuticals, Inc.
$119
Zimmer Biomet Holdings, Inc.
$115
Eisai Inc.
$113
Allergan, Inc.
$112
Avanir Pharmaceuticals, Inc.
$111
ARBOR PHARMACEUTICALS, INC.
$107
Neurelis, Inc.
$101
Supernus Pharmaceuticals, Inc.
$100
Novocure Inc.
$97
Silk Road Medical, Inc.
$95
Genentech USA, Inc.
$87
Impax Laboratories, Inc.
$87
Horizon Therapeutics plc
$85
CSL Behring
$81
Merz North America, Inc.
$80
W. L. Gore & Associates, Inc.
$79
Allergan Inc.
$78
Upsher-Smith Laboratories LLC
$68
Scilex Pharmaceuticals Inc.
$67
Takeda Pharmaceuticals U.S.A., Inc.
$65
Otsuka America Pharmaceutical, Inc.
$65
SCILEX PHARMACEUTICALS INC.
$62
MERZ NORTH AMERICA, INC.
$55
Medtronic USA, Inc.
$55
Neurocrine Biosciences, Inc.
$53
Corium, LLC
$49
Merz Pharmaceuticals, LLC
$48
AbbVie, Inc.
$41
Boston Scientific Corporation
$36
ASSERTIO THERAPEUTICS, Inc.
$35
Amylyx Pharmaceuticals, Inc.
$33
Avion Pharmaceuticals
$30
Bayer HealthCare Pharmaceuticals Inc.
$29
Mallinckrodt LLC
$29
IMPEL PHARMACEUTICALS INC.
$28
Bausch Health US, LLC
$28
Life Molecular Imaging Ltd
$27
Xeris Pharmaceuticals, Inc.
$26
Aprecia Pharmaceuticals, LLC
$24
Cala Health, Inc.
$21
CATALYST PHARMACEUTICALS, INC.
$20
Nevro Corp.
$19
Medtronic, Inc.
$18
Ipsen Biopharmaceuticals, Inc
$18
Mallinckrodt Hospital Products Inc.
$18
UPSHER-SMITH LABORATORIES LLC
$16
Alnylam Pharmaceuticals Inc.
$16
Vanda Pharmaceuticals Inc.
$15
Abbott Laboratories
$15
GE HealthCare
$15
Kowa Pharmaceuticals America, Inc.
$15
MDD US Operations, LLC
$14
US WorldMeds, LLC
$14
Zyla Life Sciences, Inc.
$13
Zyla Life Sciences
$13
Validus Pharmaceuticals LLC
$12
BIOTRONIK INC.
$12
Cycle Pharmaceuticals Inc
$12
Top 3 companies account for 26.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · Betaseron · Biowick · Briviact · CALA TRIO · COMIRNATY · CONTRAVE · COPAXONE · Cambia · DUOPA · Dhivy · Duopa · Dysport · ELYXYB - CELECOXIB · EMGALITY · ENROUTE Transcarotid Neuroprotection System · Equetro · FIRDAPSE · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · GVOKE PFS · Gamunex-C · General - DBS · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · KISUNLA · LEMTRADA · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONZETRA XSAIL · OXTELLAR XR · Omnia · Ongentys · Optune · PAXLOVID · PONVORY · PROCLAIM · Ponvory · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QULIPTA · RELYVRIO · REXULTI · RYTARY · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · Seglentis · Soliris · Spritam · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tascenso ODT · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XEOMIN · Xadago · Xeomin · ZEPOSIA · ZTLido · Zinbryta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
56
County median income
$122,727
Nearest hospital to ZIP centroid (approximate)
MONMOUTH MEDICAL CENTER
7.4 mi
7.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Deutsch is a clinical cardiology specialist, with above-average Medicare volume (top 20% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Deutsch experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Deutsch performed 545 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Deutsch receive payments from pharmaceutical companies?
Yes. Dr. Deutsch received a total of $16,948 from 88 companies across 1,222 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Deutsch's costs compare to other neurologists in Neptune?
Dr. Deutsch's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Deutsch) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Neptune
Browse neurologists in Neptune ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology